uploads///cannabis top  stocks

Why Canadian Cannabis Sales Dipped Slightly in April


Jun. 22 2020, Updated 12:39 p.m. ET

In March, Canadian cannabis sales hit a new record with sales of 181.1 Canadian dollars, as reported by Statistics Canada. Concerns about the shortfall of cannabis due to the COVID-19 outbreak led customers to pile up their inventories. As a result, there was a sharp rise in marijuana sales. In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing, Canadian retail sales fell by 26.4% during the same month.

Article continues below advertisement

The sales across the ten Canadian provinces weren’t consistent. Among the ten provinces, six reported lower sales, while four provinces reported sales growth. In Ontario, Canada’s largest cannabis market, cannabis sales declined by 9.6%. As reported by Marijuana Business Daily, cannabis retailers in Ontario had to close their stores in April due to emergency orders. However, they were allowed to operate later in the month through curbside pickup and home delivery. The store closures and restrictions on cash payments impacted cannabis sales in April, as reported in the Marijuana Business Daily article. Prince Edward Island reported the steepest fall in cannabis sales with sales declining by 63.7%. Other provinces, like Manitoba, British Columbia, Nova Scotia, and Newfoundland and Labrador also reported lower sales.

Meanwhile, Quebec reported 9% month-over-month growth in April with its cannabis sales rising to 41.0 million Canadian dollars. Alberta, Saskatchewan, and New Brunswick reported sales growth of 4.7%, 5.6%, and 9.5%, respectively.

Cannabis sector performance

On June 19, the cannabis sector was down. The ETFMG Alternative Harvest ETF (NYSE:MJ) and the Horizons Marijuana Life Sciences Index ETF (TSE:HMMJ) closed 1.1% and 0.9% down, respectively. Weakness in the broader equity markets dragged the marijuana sector down. The S&P 500 Index closed 0.5% lower due to the fear of rising COVID-19 cases and a slowdown in the economy’s recovery.

So far June, the marijuana sector has underperformed the border equity markets. MJ and HMMJ have fallen by 1.8% and 1.7%, respectively. Meanwhile, the S&P 500 Index has increased by 1.8% during the same period. Prominent marijuana players Canopy Growth (TSE:WEED), Aurora Cannabis (NYSE:ACB), and HEXO (TSE:HEXO) have returned -2.4%, -5.7%, and 20%, respectively. Earlier this month, HEXO reported an impressive third-quarter performance. To learn more, read Hexo Beat the Revenue Estimates, Posted Q3 Loss.


More From Market Realist

  • Flora Growth logo and woman looking at marijuana plants
    What to Expect From the Flora Growth IPO This Week
  • Trulieve and Harvest Health logos over marijuana
    Trulieve Acquires Harvest Health in Multi-Billion Dollar Deal
  • Tilray logo over marijuana harvest
    Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes
  • Marijuana plant
    What the Tilray and Aphria Merger Means for Investors
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.